Following a decision to stop selling certain DNA-based human-identification products in China’s Xinjiang region “almost five years ago,” instrumentation maker Thermo Fisher Scientific, said it will no longer sell like products in Tibet, James Areddy wrote for the Wall Street Journal. The use of the company’s technology by authorities in China and Tibet to “identify and track people in a manner” the U.S. government classifies as abusive and complaints from human-rights groups led to the halt, added the story.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on TMO:
- GlycoMimetics in manufacturing pact with Thermo Fisher for uproleselan
- HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections
- Hamilton Thorne CEO David Wolf retires, Ekaterina Torchilin to succeed
- Thermo Fisher initiated with a Buy at HSBC
- Thermo Fisher initiated with neutral view at Wolfe Research, here’s why